Group T1 T2 T3 T4 T5
INR C 1.85 ± 0.40 2.10 ± 0.45* 1.91 ± 0.22 2.14 ± 0.30* 2.40 ± 0.27*
R 1.89 ± 0.43 1.13 ± 0.13*# 1.27 ± 0.17*# 2.29 ± 0.49* 2.56 ± 0.31*
APTT
SEC
C 60.90 ± 17 66.84 ± 14.24 77.52 ± 15.7** 90.5 ± 9.9** 92.48 ± 12.30**
R 58.80 ± 12.57 42.54 ± 9.55**# 58.94 ± 8.69# 96.6 ± 14.8** 92.04 ± 7.56**
Platelets/mm3 C 58.8 ± 25.9 63.7 ± 24.43 63 ± 13.42 49.1 ± 13.9 47.56 ± 9.97
R 62.64 ± 27 64.68 ± 26 61.76 ± 19.60 50.08 ± 15.19 50.52 ± 73.13
Fibrinogen (mg/dl) C R 126 ± 37.3 120.6 ± 24.63 93 ± 24.65* 66.7 ± 16.7* 58.8 ± 11.68*
  130 ± 75.2 98.8 ± 48*# 89.6 ± 50.7* 55.6 ± 18.*# 49.8 ± 16.34*#
C, Control group R, rFVIIa group INR, International Normalization Ratio T1, preoperative T2, half an hour after the first dose T3, half an hour after the second dose T4, after reperfusion T5, at the end of surgery. * P<0.05 relative to the preoperative value of the same group is considered statistically significant. # P<0.05 relative to the similar value of C group is considered statistically significant
Table 3: Conventional coagulation changes of both groups.